The invention relates to a fluid pump or rotary cutter having at least one first element (9′″, 10′″) which can be brought from a transport state into an operating state by changing at least one mechanical property. Such a pump can, for example, be a blood pump for the medical, microinvasive area. The object of achieving a transition between the transport state and the operating state which is as comfortable as possible and in so doing leaving a freedom in the design of the corresponding apparatus, in particular of a pump, which is as large as possible, is achieved using the means of the invention in that the first element at least partly comprises a material (24, 25, 26, 27) or can be filled with a material or material mixture which passes through a chemical reaction, in particular cross-linking, or a crystallization for transition into the operating state.

Patent
   10413646
Priority
Mar 05 2010
Filed
Jan 17 2018
Issued
Sep 17 2019
Expiry
Mar 02 2031

TERM.DISCL.
Assg.orig
Entity
Large
13
243
currently ok
17. A method for operating a pump; the method comprising:
inserting a percutaneous blood pump into patient's body, the blood pump including a rotor blade configured to be filled with a material which passes through a material conversion;
transitioning the rotor blade from a compressed state to an expanded state; and
providing power to rotate the rotor blade of the pump;
wherein the material of the rotor blade undergoes a material conversion during the transitioning of the rotor blade from the compressed state to the expanded state, wherein the material has a first material property in the compressed state and a second material property in the expanded state.
1. A pump for operation in a fluid, the pump comprising:
at least one rotor blade, the rotor blade having a compressed state in which the rotor blade is compressed to a first size and the rotor blade also having an expanded state in which the rotor blade is expanded to a second size, the second size being larger than the first size;
wherein the rotor blade comprises at least in part a material, wherein in the compressed state the material is configured to have a first material property and in the expanded state the material is configured to have a second material property; and
wherein the material passes through a material conversion when the rotor blade changes between the compressed state and the expanded state.
2. The pump of claim 1, wherein the material conversion is a chemical conversion.
3. The pump of claim 1, wherein the material conversion is a rheological conversion.
4. The pump of claim 1, wherein the first material property and the second material property are a first and second stiffness.
5. The pump of claim 1, wherein the rotor blade has a first shape in the compressed state and a second shape in the expanded state following the material conversion.
6. The pump of claim 1, the pump further comprising a hub coupled to the at least one rotor blade.
7. The pump of claim 6, wherein in the compressed state the rotor blade is compressed onto the hub.
8. The pump of claim 7, wherein in the expanded state the rotor blade extends outwards from the hub.
9. The pump of claim 6, wherein the first size is a first diameter measured from the hub and the second size is a second diameter measured from the hub.
10. The pump of claim 1, wherein the first size is a first length of the rotor blade and the second size is the second length of the rotor blade.
11. The pump of claim 1, wherein the material conversion is initiated by a temperature effect.
12. The pump of claim 1, wherein the material conversion is initiated by an electric field.
13. The pump of claim 1, wherein the material conversion is initiated by a magnetic field.
14. The pump of claim 1, wherein the material conversion is initiated by radiation.
15. The pump of claim 1, wherein the material conversion is initiated by the addition of a further material.
16. The pump of claim 1, wherein the material conversion is reversible.
18. The method of claim 17, the method further comprising introducing the material into at least one hollow space of the rotor blade prior to the transitioning of the rotor blade.
19. The method of claim 18, the method further comprising applying a stimuli to the pump to initiate the material conversion, wherein the stimuli is one of radiation, temperature change or mechanical effect, or electric or magnetic fields.
20. The method of claim 19, wherein the pump is exposed to the stimuli after its introduction into the patient's body and power is provided to the pump during the application of the stimuli; or in that the pump is exposed to stimuli during transport.

This application is a continuation of U.S. patent application Ser. No. 14/942,158 (allowed) filed on Nov. 16, 2015, which is a continuation of U.S. patent application Ser. No. 13/261,423 (now issued as U.S. Pat No. 9,217,442), which entered the national stage on Nov. 14, 2012 and which is a United States National Stage filing under 35 U.S.C. § 371 of International Application No. PCT/EP2011/001125, filed Mar. 2, 2011, which claims the benefit of U.S. Provisional Patent Application No. 61/310,750, filed Mar. 5, 2010, and European patent Application No. 10075103.1, filed Mar. 5, 2010, the contents of all of which are incorporated by reference herein in their entirety. International Application No. PCT/EP2011/001125 was published under PCT Article 21(2) in English.

The invention is in the field of mechanical engineering and precision engineering and can be used to particular advantage in apparatus which are conveyed to a deployment site in a transport state and are there brought into an operating state before they are started.

This is, for example, sensible with devices which have to be conveyed to sites which are difficult to access in order to be used there, for example pumps or machining tools in contorted hose systems or pipe systems.

In the microscopic scale, such devices can be used as microinvasive devices, for example pumps or rotary cutters in human or animal vessels, for example blood vessels or other bodily cavities.

In this respect, it is difficult to introduce these devices through the body's own vessels since the corresponding dimensions have to be kept very small for this purpose, with simultaneously larger dimensions being sensible in operation for the efficiency of use.

In the field of catheter pumps, in particular of blood pumps, radially compressible pumps have already been proposed to solve this problem which are kept in a transport state with small radial extent during transport and which can be radially expanded at the deployment site, for example in a ventricle, after introduction there.

For this purpose, complex and/or expensive mechanical constructions are known which serve the erection of conveying elements of a rotor. In addition, it is often necessary to stabilize the corresponding conveying elements such as conveying blades in operation since they are exposed to considerable fluid forces in operation.

A compressible rotor is known, for example, from U.S. Pat. No. 6,860,713. In addition, a further rotor is known from U.S. Pat. No. 7,393,181 B2. In the solutions known from the patent literature, provision is made in part that a rotor is compressible by elastically deformable conveying blades or that erection mechanisms for conveying blades are provided which are otherwise laid at the side of the rotor when it is stationary.

In addition to the compressibility of the rotor, it can also be advantageous or sensible to configure the pump housing, which can surround the rotor, in a correspondingly compressible manner.

In this respect, there is as a rule the problem that, on the one hand, the construction and the materials of the rotor should be stable in operation in order reliably to convey the fluid at high speeds and that, on the other hand, a certain yielding of at least parts of the rotor is desirable to keep the forces which are necessary for the compression of the rotor or of the pump within limits.

A technique is known from WO 2009/132309 to bring stents into a desired form after the introduction into a blood vessel by introducing a hardenable medium and subsequently to stabilize them in an operating state.

It is the underlying object of the present invention against this background to configure a corresponding apparatus for a mechanical action on a medium, in particular on a fluid pump or a rotary cutter, such that it can be sensibly brought from a transport state into an operating state, wherein the transport state has a particular suitability for transport, whereas the operating state differs from this and is in particular suitable for the operation of the apparatus/pump.

The object is achieved by the features of the invention in accordance with claim 1.

Since the first element comprises a material or is filled or fillable with a material or a material mixture which passes through a chemical reaction on transition into the operating state, for example a cross-linking or a transition from the liquid state into a solid state or a change in the rheological state and thus at least changes a mechanical property, it is possible to implement a lower stiffness or a lower viscosity in the transport state of the first element, for example, than in the operating state. For example, the first element can be a conveying element, for example a conveying blade of a rotor of a fluid pump or a bracing element of a rotary cutter so that, on a lower stiffness, the corresponding conveying element can be laid onto a hub and the corresponding rotor is thus easily compressible. In this state, the rotor can also be self-compressible in that, in the state of rest, the conveying elements lie on the hub and are only erected on being put into operation by centrifugal forces.

In order then to ensure a higher stiffness of the conveying blades or conveying elements in operation, the material of which the conveying blade or a part of the conveying blade is composed is selected such that it undergoes a hardening or stiffening when passing through the corresponding reaction or the transition, in particular the transition into a different state of aggregation, for example a crystallization.

Provision can also be made that the first element, that is, for example, the conveying element, has hollow spaces which can be filled with a corresponding material, for example via feed hoses, and which can then be hardened, stiffened or, when it is a case of a liquid, whose viscosity can be changed.

The change of the viscosity can be effected, for example with magnetorheological or electrorheological liquids, by applying a magnetic field or an electric field from outside a patient's body. A corresponding field can, however, also be effected by coils or electrodes in the body in the direct vicinity of the pump/rotary cutter. The field generating elements can also be directly fastened to the pump/rotary cutter.

In this respect, it is not the whole element which has to change its properties accordingly, but it is rather sufficient, for example, if a joint connecting the conveying element to a hub is stiffened by the corresponding reaction or changes its shape and thereby radially expands or erects the conveying element.

Provision can also be made that the first element represents another part of a rotor of a fluid pump or that a pump housing has accordingly to be brought into an operating shape or a stiffness corresponding to the operation.

In this case, as with a corresponding use with a rotor, hollow spaces can also be provided which can, for example, be filled with a fluid under pressure and can thus be inflated to give the corresponding first element a desired shape, whereupon the material can be hardened or stiffened to keep this shape stable.

Alternatively to the stiffness, a different mechanical property such as the geometrical shape or size can be changed by the corresponding reaction. For example, a part of a conveying blade can be shorted or extended in the manner of a shrinking hose by the reaction and thereby, that is, by means of lever forces, erect or stiffen the conveying blade.

The material of which the first element is composed in part or with which it can be filled, can, for example, be a hardenable material, in particular a hardenable plastic.

A hardening can take place for transition into the operating state, for example by temperature effect or pressure effect, electric and/or magnetic fields or pulses, radiation (IR light or UV light, α, β, γ radiation), mechanical effect, e.g. ultrasound or vibration, or can also be brought about by contact with a further material or by initialization of a crystallization with a liquid material.

The further material can in this respect be a real reaction partner which likewise reacts in the reaction and undergoes a conversion or it can be a catalyst or enzyme which, when added, results in an acceleration of the reaction.

The further material can, for example, be included in the medium on which the apparatus should act, for example in the body fluid in which a corresponding fluid pump should be operated. In this case, the body fluid can diffuse on the introduction of the apparatus into a body and the desired reaction can then take place before the start of operation either automatically or initiated or assisted by additional measures. The first material can for this purpose e.g. comprise a protein or consist of a protein.

It becomes possible by the invention to ensure mechanical properties for the operation of the apparatus, for example the pump, which would be disadvantageous during the transport to the deployment site and which can be avoided by the invention. These properties are only achieved after the bringing to the deployment site with the end of the corresponding reactions. The corresponding reactions can be reversible, but also irreversible.

An advantageous embodiment of the invention further provides that the first element can be changed by a continued or further reaction, reversibly or irreversibly, into a state in which the apparatus can be transported or in which it can be brought into a transport state by mechanical destruction.

For example, by continuing the reaction which was passed through before the operating state was reached, a further change of the mechanical properties can take place, e.g. by (cross-linking) embrittlement of the material of which the first element is wholly or partly composed. This embrittlement can, for example, go so far with a synthetic resin that the corresponding parts can break by themselves or can at least be easily broken in order again to achieve a suitable transport state for the return transport of the apparatus/fluid pump. A different reaction can, however, also be provided to achieve the corresponding desired result.

In addition to the apparatus in accordance with the invention, the invention also relates to a method in which the apparatus is first introduced into a body of a living being, wherein the material/the material mixture of the first element thereupon undergoes a reaction, in particular a cross-linking, or a crystallization from the liquid phase, before the apparatus is started.

By such a handling, the apparatus is first brought to the deployment site within a body of a living being in the transport state and is only there brought into the operating state with respect to the mechanical properties and thus into a form efficient for operation.

Provision can particularly advantageously be made that the or a material is introduced into at least one hollow space of the first element before the reaction.

For example, a hollow space or a series of hollow spaces, which can be formed, for example, by bubbles of a foam of which the first element is composed, can be filled via hoses with a material which can either itself pass through a reaction to change its mechanical properties or which meets a further material in the hollow spaces and reacts accordingly with it, or wherein one of the materials serves as a catalyst for the reaction.

The actual reaction can in this respect be initiated, assisted or carried out by a corresponding influencing from outside, wherein, for example, radiation, temperature change, mechanical action, such as ultrasound, or the action by electric and/or magnetic fields can serve for this purpose.

The invention moreover relates to a fluid pump or rotary cutter having at least one first element which can be brought from a transport state into an operating state by changing at least one mechanical property, wherein the first element at least partly comprises a material or can be filled with a material or material mixture which, as long as it is exposed to a radiation or an electric and/or magnetic field, has mechanical properties, in particular with respect to stiffness, viscosity, size and/or shape, changed compared with the state without such an action.

Examples for such a change of the mechanical properties by fields are the piezoelectric effect and magnetorestriction or with liquids the magnetorheological effect or the change of the viscosity by electric field effect.

A corresponding method in accordance with the invention for putting such an apparatus into operation provides that the apparatus is exposed to the corresponding action to make the apparatus operable after its introduction into a body of a living being. The action usually has to be maintained during the operation of the apparatus/fluid pump. Neither a reversible nor an irreversible chemical reaction has to take place in this respect, but rather only a different mechanical state of the material is adopted in dependence on the action.

In a modification, the invention can also be configured so that the corresponding action is maintained in the transport state and is removed or is omitted for reaching or during the operating state.

Different mechanisms usable in situ can be considered for the direct change of the mechanical properties of the mentioned elements, in particular the elements of pumps and rotary cutters, including mechanisms in the chemical field, in particular cross-linking.

Cross-linking in macromolecular chemistry refers to reactions in which a plurality of individual macromolecules are linked to form a three-dimensional network. The linking can be achieved either directly on the buildup of the macromolecules or by reactions on already existing polymers. Examples for directly cross-linking reactions are radical polymerizations of monomers having two vinyl functions or the polycondensation or polyaddition using monomers having two or more functional groups. The cross-linking of already existing polymers can take place either via functional groups already present in the polymer by an adroit choice of the reaction conditions (so-called self cross-linkers) or by the addition of multifunctional low-molecular substances, the cross-linking agents. The hardening of epoxy resins using amines and the addition of substances containing sulfur on the vulcanization of rubber are examples for cross-linking reactions.

Generally synthetic resins, polyvinyl chloride (PVC), vulcanized rubber, polyethylene, PMMA, polypropylene, PET, PTFE, polyurethanes, polyesters, polyamides, polystyrene and proteins (example: keratin) are known as cross-linkable materials. The biocompatibility naturally has to be considered on the selection for the use in accordance with the invention. Optionally, less suitable materials can only be used as a filling for hollow bodies.

The individual material classes in detail:

In accordance with DIN 55958, synthetic resins (also called reaction resin) are synthetically manufactured by polymerization reactions or polycondensation reactions. They can be modified by natural substances, for example vegetable or animal oils or natural resins, or manufactured by esterification or saponification of natural resins.

Synthetic resins as a rule comprise two main components. The mixture of both parts (resins and hardeners) produces the reactive resin compound. The reaction process is largely dependent on the environmental temperature and the material composition can often be selected so that the hardening reaction only takes place at a noticeable speed on a heating to body temperature. On hardening, the viscosity increases and when the hardening is complete a non-meltable (thermosetting) plastic is obtained.

A polymerization can also be initiated in a variety of plastics by the application of radiation (particle radiation (alpha or beta particles), or also X-ray radiation or gamma radiation or UV radiation). There are, e.g. in dental engineering, excellent UV-hardening adhesives which are also correspondingly biocompatible.

Radiation cross-linking gives inexpensive bulk plastics or technical plastics the mechanical, thermal and chemical properties of high-performance plastics. This refining of plastics allows a use under conditions which these plastics would otherwise not withstand. The high-energy beta or gamma radiation triggers chemical reactions in the plastic parts and thus results in a cross-linking of the molecules—comparable to vulcanization in rubbers.

The cross-linking of polyethylene, polyamide, PVC and PBT is the most significant from a quantity aspect.

The cross-linking of thermoplastic elastomers (TPO, TPC and TPA) is increasingly gaining importance. A cross-linking of polypropylene is generally also possible although degradation reactions predominate with this material as a rule. The following can apply as a general rule: Radiation cross-linking is always possible when chemical cross-linking by means of radical initiators such as peroxides is possible.

The advantage of radiation cross-linking is that the method works at room temperature or at body temperature and at normal pressure.

The radiation for hardening takes place after or during the molding or deforming. A direct deforming can, however, also take place by the radiation itself and by an accompanying cross-linking and desired shrinking or stretching of the material thus treated. The advantageous processing properties of thermoplastics are thus combined with the properties of thermosetting systems.

Rubber is mainly manufactured synthetically. Synthetic rubber is usually composed of styrene and butadiene; other raw material bases are styrene acrylate, pure acrylate, vinyl acetate. The first commercially usable one was the styrene butadiene rubber, another is neoprene.

Polyethylene (abbreviation PE) is a thermoplastic manufactured by polymerization of ethene.

Polyethylene belongs to the group of polyolefins. Known trade names include: Alathon, Dyneema, Hostalen, Lupolen, Polythen, Spectra, Trolen, Vestolen. Polyethylene is manufactured on the basis of ethylene gas which can be manufactured either conventionally in a petrochemical manner or from ethanol.

Polyurethanes (PU, DIN abbreviation: PUR) are plastics or synthetic resins which arise from the polyaddition reaction of diolen or polyolene with polyisocyanates. The urethane group is characteristic for polyurethanes.

Polyurethanes can be hard and brittle, or also soft and elastic, depending on the manufacture. The elastomers in particular show a comparatively high breaking strength. In foamed form, polyurethane is known as a permanently elastic flexible foam or as a hard expanding foam.

Polyurethanes can have different properties depending on the choice of the isocyanate and of the polyol. The density of unfoamed polyurethane varies between around 1000 and 1250 kg/m3.

The later properties are substantially determined by the polyol component because it is usually not the isocyanate component which is adapted to achieve the desired properties, but rather the polyol component. The following isocyanate components are generally used:

Mechanical properties can be influenced in dependence on the chain length and on the number of branches in the polyol. A use of polyester polyols in addition to the more usual polyether polyols results in better stability because polyester polyols have a higher melting point and thus solidify on application of the polyurethane.

The foaming of polyurethane foams arises due to the addition of water. On the reaction of water with isocyanate, carbon dioxide is split off which swells the foam. The volume weight of the arising foam can be varied by the quantity of added water. Typical densities are around 5 to 40 kg/m3 for soft slab foam or 30 to 90 kg/m3 for hard slab foam.

When polyurethanes are fully cured and no longer contain any monomers, they as a rule do not have any properties harmful to the health. Isocyanates can, however, trigger allergies and are suspected of causing cancer. The toluene diisocyanate used for some polyurethanes evaporates at room temperature and can cause damage in the lung when inhaled. Such substances are predominantly only used as filling of a closed hollow body, with subsequent hardening, located in the patient's body.

Polyurethanes arise by the polyaddition reaction of polyisocyanates with multiple alcohols, the polyols. The linking takes place by the reaction of an isocyanate group (—N═C═O) of a molecule having a hydroxyl group (—OH) of another molecule while forming a urethane group (—NH—CO—O—). In this respect, no splitting off of secondary products takes place such as in polycondensation.

The polyurethane formation by polycondensation requires at least two different monomers, in the simplest case diol and diisocyanate. It takes place in stages. First, a bifunctional molecule having an isocyanate group (—N═C═O) and a hydroxyl group (—OH) is formed from diol and diisocyanate. It can react at both ends with further monomers. In this respect, short molecule chains arise, so-called oligomers. They can react with further monomers, other oligomers or already formed polymers.

Depending on the starting materials, linear or cross-linked polymers are obtained. Linear polyurethanes can, for example, be obtained from diols and diisocyanates. Linear polyurethanes can be subsequently cross-linked by addition of further diisocyanate. Alternatively, cross-linked polyurethanes can also be manufactured by the reaction of diisocyanates or triisocyanates with polyols.

In a secondary reaction, water reacts with some isocyanate groups; in so doing, carbon dioxide is released which allows the still soft plastic to swell. The simultaneously created primary amino group reacts with an isocyanate group to form a substituted urea.

If a specific polyurethane should be manufactured in practice, two possibilities are available:

Direct reaction of a polyol with a polyisocyanate (a one-stage process)

Manufacturing a functionalized smaller polymer (so-called prepolymer) as an intermediate product which reacts in a second step to form the desired polymer by cross-linking the functional groups (a two-stage process)

Biogenic Polyols

As a rule, both the polyols and the polyisocyanates originate from the production from petrochemical raw materials; however, polyols on the basis of vegetable oils can also be used. Ricinus oil is above all suitable for this purpose since it has hydroxyl groups itself and it can be converted directly with isocyanates. Derivatives of the ricinus oil can furthermore be used. Furthermore, polyols on the basis of vegetable oils can be manufactured, on the one hand, by epoxidation of the vegetable oils with a subsequent ring opening and via a transesterification of vegetable oils with glycerin. Polyurethanes on the basis of vegetable oils are also marketed as “bio polyurethanes” due to the biogenic origin of some of the raw materials.

Polyesters are polymers having ester functions—[CO—O—]— in their main chain. Polyesters admittedly are also present in nature, but today polyesters are rather understood as a large family of synthetic polymers (plastics) which include the widely used polycarbonates (PC) and above all the technically important thermoplastic polyethylene terephthalate (PET). Mylar is a particular processing form of the polyethylene enterephthalate—as a film. A further form is the thermosetting unsaturated polyester resin (UP) which is used as an inexpensive matrix resin in the field of fiber plastic composites.

The following can be considered as the polyester:

The designation polyamides is usually used as a name for synthetic technically usable thermoplastics and thus delineates this material class from the chemically related proteins. Almost all important polyamides are derived from primary amines, that is, the functional group —CO—NH— occurs in their repetition units. In addition, polyamides of secondary amines (—CO—NR—, R=organic residue) also exist. In particular amino carboxylic acids, lactams and/or diamines and dicarboxylic acids are used as monomers for the polyamides.

Polyamides can be categorized in the following classes:

By the Kind of Monomers

Aliphatic polyamides: the monomers are derived from aliphatic base bodies, e.g. PA from ε-caprolactam (polycaprolactam, abbreviated PA 6) or from hexamethylene diamine and adipic acid (PA 66).

Partially aromatic polyamides: the monomers are derived in part from aromatic base bodies, e.g. PA from hexamethylene diamine and terephthalic acid (PA 6T).

Aromatic polyamides (polyaramides): the monomers are derived from purely aromatic base bodies, e.g. para-phenylene diamine and terephthalic acid (aramide).

By the Kind of Monomer Composition

Homopolyamides: the polymer is derived from an amino carboxylic acid or from a lactam or a diamine and an dicarboxylic acid. Such polyamides can be described by a single repetition unit. Examples for this are the PA from caprolactam [NH—(CH2)5-CO]n (PA 6) or the PA from hexamethylene diamine and adipic acid [NH—(CH2)6-NH—CO—(CH2)4-CO]n (PA 66).

Copolyamides: the polyamide is derived from a plurality of different monomers. Such polyamides can only be described by giving a plurality of repetition units. Examples for this are the PA from caprolactam, hexamethylene diamine and adipic acid [NH—(CH2)6-NH—CO—(CH2)4-CO]n-[NH—(CH2)5-CO]m (PA 6/66), or PA from hexamethylene diamine, adipic acid and sebacic acid [NH—(CH2)6-NH—CO—(CH2)4-CO]n-[NH—(CH2)6-NH—CO—(CH2)8-CO]m (PA 66/610). It must be noted that the formulae given only describe the polymer composition, but not the sequence of the monomer units; these are usually statistically distributed over the polymer chains.

By the Kind of Softening/solidification Behavior

Partially crystalline polyamides: form crystalline domains from the melt when cooling (1st order phase transition). As a rule, the whole melt does not solidify in a crystalline manner, but amorphous domains are rather also formed (see below). The ratio between the crystalline and the amorphous domains is determined by the chemical nature of the polyamide and by the cooling conditions. In addition, the crystallization can be promoted or hindered by nucleating or antinucleating additives. Polyamides which crystallize easily are e.g. PA 46 or PA 66; polyamides which crystallize with difficulty are e.g. PA mXD6 from xylylene diamine and adipic acid or certain copolyamides.

Amorphous polyamides: solidify in glass-like manner from the melt. In the solid state, there is no long-range order of the repetition units. The transition between solid and liquid is described by the glass transition temperature (2nd order phase transition). Examples are the PA from hexamethylene diamine and isophthalic acid (PA 6I) and certain copolyamides. Generally, amorphous polyamides include monomer units which make a regular, crystalline arrangement of the chains impossible. Under extreme cooling conditions, otherwise partially crystalline polyamides can also solidify amorphously.

Polystyrene (abbreviation PS, IUPAC name: poly(1-phenylethane-1,2-diyl)) is a transparent, amorphous or partly crystalline thermoplastic. Amorphous polystyrene can be used for a variety of purposes.

Polystyrene is used either as a thermoplastically processable material or as a foam (expanded polystyrene). Polystyrene is physiologically harmless. Polystyrene is predominantly gained by suspension polymerization of the monomer styrene which has exceptional polymerization properties. It can be polymerized radically, cationically, anionically or by means of Ziegler-Natta catalysts. Ethene is today acquired from crude oil. Chlorine is above all acquired on a large technical scale in chlorine alkaline electrolysis from common salt. The chlorine is added to the ethene in a first step and 1,2-dichloroethene is created. In a second step, HCl is split off therefrom, with VCM arising. VCM is polymerized in an autoclave to form PVC under pressure and under the addition of initiators and other additives. Three different polymerization processes are essentially known. The oldest process, in a historical view, is emulsion polymerization. The initiators (for example peroxides and other per compounds) are soluble in water in this case. The so-called E-PVC is obtained. If the VCM is distributed in the water by intensive stirring and if the initiator (for example organic peroxides, azobisisobutyronitrile [AIBN]) is soluble in monomers, one speaks of suspension polymerization which results in S-PVC. If no water is used during the polymerization, one speaks of block PVC or mass PVC, also called M-PVC. In this respect, the initiator is dissolved in monomeric vinyl chloride.

Magnetorheological Liquids:

The liquid used, a special magnetorheological oil, is permeated with microscopically small, magnetically polarizable metal particles. It is possible to generate a magnetic field via an electromagnet or a permanent magnet. The metal particles are thereby aligned in the direction of the magnetic field and thus decisively influence the viscosity, i.e. the flowability of the oil. By applying a voltage, the arrangement of the magnetic particles and thus the physical consistency (viscosity) of the liquid reacting almost without delay is varied.

The property of the dilatancy of a substance can also be used directly to increase the viscosity in situ. For this purpose, the effect of the so-called structural viscosity, opposite to dilatancy, will be explained.

Structural viscosity, also called shear thinning, is the property of a fluid to show a reducing viscosity at high shear forces. I.e., the higher the shear acting on the fluid, the less viscous, it is. Such a fluid is therefore aptly called shear thinning, which is occasionally used as a synonym for structural-viscous.

The reduction of the viscosity arises due to a structural change in the fluid which provides that the individual fluid particles (e.g. polymer chains) can slide past one another more easily.

Since the viscosity does not remain constant in a structural-viscous fluid as the shear increases, it is classified as a non-Newtonian fluid.

Other fluids from this classification have the following properties inter alia:

Dilatancy, the opposite behavior to structural viscosity;

Thixotropy, the viscosity does not immediately increase again after reduction of the shear force;

Rheopexy, the opposite behavior to thixotropy.

Examples:

Structural viscosity: The individual polymer chains are interlinked (=interlaced) in polymer solutions and polymer melts. As the shear force increases, these interlinks release and the viscosity drops. This effect plays a large role in the processing of thermoplastics. Lower injection pressures are therefore required in the preparation of thin-walled injection molded parts than with thick-walled ones.

Non-drip wall paint does not drip off the roller since the shear is small and the viscosity is large, whereas it is easy to apply to the wall since the thin film between the wall and the roller causes a large shear and thus the viscosity is small.

Associative materials are systems in which small molecules congregate to form supramolecular systems via physical interactions, for example hydrogen bridge bonds or ion-dipol interactions. These bonds which are weak (in comparison with covalent bonds) are broken open by shear, which lowers the viscosity. The special feature in this respect is that the bonds only completely form back after a certain material-specific time (→thixotropy). Technically important representatives are ionomers.

Dilatancy (also shear thickening) is in rheology the property of a non-Newtonian fluid to show a higher viscosity at high shear forces. A dilatants fluid is also called shear thickening or shear hardening.

The increase in the viscosity arises through a structural change in the fluid which ensures that the individual fluid particles interact more with one another (for example interlace) and so slide past one another less easily.

The viscosity of a dilatant fluid increases with the shear speed , but does not depend on the time with a constant shear speed.

If the viscosity does not immediately fall again after a reduction of the shear force, one speaks of rheopexy which is indeed time-dependent.

The US manufacturer Dow Corning produces the dilatant putty Silly Putty (also called Bouncing Putty, Thinking Putty, Smart Putty) from silicone polymer which was previously above all on the market as a children's toy. In addition to the normal kneadability, this substance behaves completely differently on a sudden mechanical strain: if a ball of the material is thrown to the ground, it bounces back up like a rubber ball; if a piece is hit very quickly with a hammer, it smashes into a number of small, sharp pieces, almost like ceramics. Sharp edges and smooth break surfaces also form on tearing apart. Technical applications were not previously known.

A material with similar properties has recently been used as an active protection system (APS), for example in motorcycle clothing: especially shaped pads which contain a dilatant compound permit the free movability of the carrier. On an abrupt blow as a consequence of a fall, however, the material “hardens” to a hard rubber-like consistency, distributes the acting forces over a larger body area and so prevents injuries.

Electrorheological Fluids (ERFs):

A distinction is made between homogeneous and heterogeneous electrorheological fluids. The homogeneous ERFs comprise e.g. aluminum salts of stearic acid. The active mechanism of the homogeneous ERFs is not known with absolute certainty. The heterogeneous ERFs comprise polarizable particles or droplets which are dispersed in an electrically non-conductive carrier fluid, e.g. silicone oil or mineral oil.

Dipoles are induced in the particles by an external electric field. The particles form chains and columns along the field lines of the electric field. This so-called Winslow chain model is the simplest structural model to explain the electrorheological effect.

Practical Application and Areas of Use Electrorheological fluids are usually used as a central component of a mechatronic system. These systems can react to different general conditions together with a housing, a high-voltage power pack and a corresponding control or regulation.

The damping properties of hydraulic bearings can thus, for example, be controlled by the use of an electrorheological fluid in that the viscosity of the electrorheological fluid is controllable. When such a bearing is used as an engine bearing in an automobile, the damping could be matched dynamically to the speed of the engine and to the property of the ground to reduce the noise strain for the occupants.

Electrorheological fluids are just as loadable as their base materials. When used as a variable brake, modern ERFs are, unlike solid brakes, not abrasive and are comparatively temperature stable. There are, however, also ERF formulations which can be used as abrasives due to their high abrasiveness.

The research and development of the past years have resulted in considerable improvements both in the rheological properties and in the electric properties of electrorheological fluids. In this respect, the development has in particular concentrated on ERFs from polymer particles. Abrasion and wear no longer play any role with these electrorheological suspensions, e.g. of polyurethane particles, dispersed in a silicone oil as a carrier. The soft and elastic particles have, on the one hand, no abrasive influence on the mechanical components of the ER systems (pumps, valves); on the other hand, they are themselves extremely resistant to mechanical wear due to their flexibility so that no degradation of the ERF itself is to be seen even under the most vigorous mechanical load.

The invention will be shown and subsequently described in the following with reference to a plurality of embodiments in a drawing.

There are shown

FIG. 1 schematically in a longitudinal section, a blood vessel with a hollow catheter introduced into it and a rotary cutter;

FIG. 2 schematically, a blood vessel which opens into a ventricle and through which a hollow catheter having a heart pump is pushed in;

FIG. 3 a rotor or a pump in the transport state;

FIG. 4 the rotor of FIG. 3 in the operating state;

FIG. 5 a further rotor in the transport state;

FIG. 6 the further rotor of FIG. 5 in the operating state;

FIG. 7 a third rotor in the transport state;

FIG. 8 the rotor of FIG. 7 in the operating state during the stiffening process;

FIG. 9 a detail of a rotor with a conveying element which has a hollow space which is partially filled;

FIG. 10 the detail of FIG. 9, with the hollow space being completely filled;

FIG. 11 schematically, a view of a rotor in the transport state with a pump housing which is collapsed;

FIG. 12 the pump of FIG. 11 in the operating state;

FIG. 13 a rotor in the operating state in stiffened form with a housing of a pump in the operating state;

FIG. 14 the parts of the pump of FIG. 13 after a further treatment which allows the breaking of the conveying elements;

FIG. 15 a rotor with conveying elements which is pushed through a hollow catheter in the transport state;

FIG. 16 the rotor of FIG. 15 which is erected by withdrawing the hub into the hollow catheter;

FIG. 17 a rotor which is erected by displacement of a support wheel by means of thrust elements; and

FIG. 18 a view of the thrust wheel.

FIG. 1 shows, as an example for an apparatus in accordance with the invention, a rotary cutter 1 which is introduced at the distal end of a hollow catheter 2 into a blood vessel 3 of a human body to eliminate a constriction 4 by cutting away deposits at the wall of the blood vessel. A shaft 5 runs within the hollow catheter 2, said shaft being configured for a rotation at high speed and being able to be driven by a motor from outside the hollow catheter.

The rotary cutter 1 is advantageously first introduced into the blood vessel 3 in a transport state, for example in radially compressed form, and is then changed into an operating state on site which can, for example, differ from the transport state in that the cutter head is radially enlarged or stiffened. The invention solves the problem of effecting this change in the mechanical properties of the rotary cutter in a favorable form after passing through the transport path.

FIG. 2 shows a further example application for an apparatus in accordance with the invention which is in this case formed by a heart catheter pump 6. The latter has a housing 7 in which a rotor is accommodated which has a hub 8 and conveying elements 9, 10 in the form of conveying blades.

The pump typically has a larger diameter in operation than during the transport in order to give it the required efficiency. For this reason, the pump is radially compressed before the introduction into a blood vessel 11 through which it should be pushed into a ventricle 12. Then it is introduced through a sluice 13 into the blood vessel 10 and is pushed through up to the ventricle 12. The pump, for example the rotor and the pump housing, is then radially expanded together or each part on its own. The invention can generate the expansion movement per se or assist it. It can, however, also only become effective after the expansion movement in that, for example, the rotor or the pump housing is stiffened in the expanded position and is thus stabilized.

The pump can then be operated at high speeds and under high mechanical load in that the motor 14 drives the shaft 15 at 10,000 r.p.m., for example.

The erection of the individual elements of the pump 6 after the bringing to the deployment site in the ventricle 12 can take place, for example, in that the rotor 8, 9, 10 is set into rotation and is erected either by the acting centrifugal forces or by the counter fluid forces which are adopted on the rotation or by both together. In addition or alternatively, mechanical apparatus such as pulls or compression devices can also be provided which can be actuated along the hollow catheter 16 from outside the patient body and which act on the pump head and there cause or assist a corresponding expansion movement. Other mechanisms are also possible via which it is possible to work toward an expansion. They will be explained by way of example with reference to the other Figures.

FIG. 3 shows a view of a rotor having conveying blades or rotor blades 9′, 10′ which are arranged at a hub 8′ and which are still shown in the transport state in FIG. 3 in which they lie radially at the hub 8′.

A respective part region 17, 18 of each conveying element 9′, 10′ is designed such that it contracts through certain external influences such as radiation with UV light or particle radiation, (α, β, γ radiation), electric and/or magnetic fields, ultrasound or mechanical strain. Self cross-linking plastics which harden, on the one hand, and contract, on the other hand, on the cross-linking can be selected as the materials 17, 18, for example.

FIG. 4 shows that the conveying elements 9′, 10′ are pulled more to the hub 8′ in their regions by a contraction of the regions 17, 18 and are thus radially erected, as indicated by the arrow 19. This effect is stable and permanent with a permanent cross-linking. It is, however, also conceivable to use materials which show such a contraction temporarily, for example by effects of magnetorestriction or piezoelectric effect. In the last-named case, the rotor is only radially expanded for so long as (or with an effect only in the transport state until) the corresponding fields act. Otherwise the rotor stabilizes and the external effect can be omitted without the rotor becoming unstable.

It is also conceivable to manufacture the whole region of the conveying elements in the region of the hub from a corresponding material which either contracts or stiffens, wherein the geometry has to be selected accordingly to achieve an automatic erection of the conveying elements if the erection is not achieved by another effect, for example by manipulation by means of wire pulls or similar. If the expansion is achieved by other effects, it may be sufficient to stiffen parts of the conveying elements 9′, 10′ or the total conveying elements in that they are manufactured from a corresponding cross-linkable material or from a material which stiffens under a corresponding effect. Elastomers already exist, for example, which react to magnetic fields by stiffening.

A further embodiment of the invention is shown in FIG. 5 having a rotor with a hub 8″ and two conveying blades 9″, 10″ and hollow spaces 20, 21 arranged therein.

The hollow spaces 20, 21 are connected to a pressure source via a line system having feeds 22, 23 which extend through the hub 8″. Corresponding lines can be fed either through a lumen of the hollow catheter or through hoses additionally arranged inwardly or outwardly at the hollow catheter there.

A gas or a liquid can, for example, be fed into the hollow spaces 20, 21 for erecting the conveying elements 9″, 10″ so that the conveying elements 9″, 10″ are erected and tightened as shown in FIG. 6. A corresponding pressed-in liquid in the hollow spaces 20, 21 is then solidified either by cross-linking or by a chemical reaction with a further material or the properties of the liquid are changed by a field effect, which is, for example, possible with magnetorheological liquids by the effect of a magnetic field and a corresponding change in the viscosity and with electrorheological properties by electric fields. The rotor is thus stabilized and stiffened at a high viscosity of the liquid.

If a gas is first pressed in, a further substance must then be introduced to maintain the stiffening permanently. A plurality of substances can, for example, also be introduced in the form of liquids and/or gases which either react with one another after meeting in the hollow spaces 20, 21 or which are added to by a catalyst as soon as the conveying elements 9″, 10″ are erected to accelerate the reaction. If an irreversible reaction is triggered by the external effect, the effect can be removed after the stiffening of the rotor. On the other hand, the maintenance, for example of a field, can also be necessary to maintain the corresponding desired mechanical properties of the rotor.

The pressing of the gas into the hollow spaces can also be utilized exclusively for the erection of the conveying elements if then other elements of the rotor are stiffened for stabilizing this state.

FIG. 7 shows a rotor having two conveying elements in the form of impeller blades 9′″, 10′″, wherein each of the conveying elements has two stiffening webs 24, 25, 26, 27. They are still flaccid in the transport state of FIG. 7 so that the conveying elements 9′″, 10′″ can contact the hub 8′″.

After being brought to the deployment site, the rotor is set into rotation, as designated by the arrow 28 in FIG. 8, so that the conveying elements 9′″, 10′″ are erected by centrifugal force and/or fluid counter-pressure. At this time, the reaction can start for stiffening the webs 24, 25, 26, 27, either by radiation such as by means of an influencing source 29, which can, however, also be replaced by a magnetic or electric field source, or by an ultrasound source or by a chemical reaction which can be triggered or conveyed by diffusing in a substance 30 in which the conveying elements move. This substance can, for example, be present in human blood as a component of the blood in natural form before the pump is used. If this substance diffuses into the conveying elements and meets the reinforcement or stiffening webs, a hardening reaction takes place there which stiffens the conveying elements.

FIG. 9 schematically shows a single conveying element 31 having a hollow space 32 which is partially filled with a liquid 33.

Provision is made for erecting and/or stiffening the conveying element 31 that a gas flows in along the arrows 34, 34 through a lumen in the hub 8″″ and the conveying element 31 into the hollow space 32 and reacts there with liquid 33 while forming a foam. An expansion by which the hollow space 32 is pressurized and inflated takes place hereby and by the corresponding reaction. At the same time, the foam 36 is stiffened, either by the reaction or by a subsequent hardening and thus stabilizes the conveying element 31, as shown in FIG. 10.

FIG. 11 shows a pump in the transport state having a pump housing 36 in the form of a membrane which is collapsed and tightly surrounds the likewise compressed rotor having the conveying blades 37. The housing 36 is fastened to the end 38 of the hub 39 and is pushed in this state at the end of a hollow catheter through a blood vessel.

If the pump head is pushed through the aortic arch and into a ventricle in a use as a heart pump, the rotor can slowly be set in motion, as shown in FIG. 12. The conveying blades 37 are erected by the centrifugal force and/or by fluid counter forces of the blood to be conveyed, suck blood through openings at the front side of the housing 36, indicated by the arrows 40, 41, and thus increase the pressure in the inner space of the pump housing 36. The membrane 36 is hereby widened and inflated and tautens tightly. At the same time, the space for the complete unfolding of the conveying blades 37 opens so that the rotor can take up its full rotational speed. The blood can then be pressed from the inner space 42 of the pump housing 36 through the openings 43 into the blood vessel 10.

The pump housing 36 is in this respect supported on the distal end 44 of the hollow catheter 45, with the drive shaft 46 which ends at the hub 47 also extending through the hollow catheter 45. The hub 47 is sensibly rotatably supported at both ends of the pump housing 36.

If the operating state is achieved by complete unfolding of the rotor or of the conveying blades 37 and pumping up the pump housing 36, the pump can thus be stabilized in this state by hardening both of the pump housing and of the conveying blades. This is done, for example, by radiation from outside with UV light, another radiation or ultrasound or by a chemical effect either by addition of a suitable substance starting a reaction at the conveying elements or at the pump housing or by reaction with a substance which is anyway in the blood to be conveyed and which acts as a reaction partner or as a catalyst.

Alternatively to this, a temporary stiffening or increase of the viscosity can also be provided here in the case of filling liquids by using magnetic or electric fields.

Corresponding fields can be introduced or radiated in from outside the patient's body or they can be applied by corresponding probes which are brought into the vicinity of the pump or are arranged at the end of the hollow catheter carrying the pump.

In an embodiment which can also be protected as a separate invention, a motor can be arranged at the pump head, for example with a corresponding pump, said motor generating a magnetic rotary field by means of its coil when switched on. Since said rotary field also rotates at the speed of the rotor, it represents a stationary magnetic field with respect to the impeller blades of the rotor which can therefore—in addition to the drive function—influence the magnetorheological fluid of the rotor blades in order to stabilize them. In a further embodiment, likewise protectable on its own, a coil without a drive function can also be arranged at the pump head, said coil effecting the stabilization of the corresponding rotor, wherein the rotor would be driven by a separate drive, for example by a flexible shaft.

It is also possible for all embodiments shown in this application, as well as also independently thereof, that electromagnetic radiation such as light, UV radiation, infrared radiation, short waves or X-ray radiation is, for example, conducted to the pump head to cause a hardening reaction there. This can take place, for example, via a suitable optical fiber which can be conducted, for example, through the hollow catheter.

FIG. 13 schematically shows a pump head having a housing 36 and conveying blades 37 which have reinforcing ribs 48. They are typically stiffened to stabilize the operating state, for example by cross-linking of a cross-linkable polymer.

To solve the problems which may occur in a patient on the removal of the pump head after the treatment, it is necessary to compress the conveying blades 37. This can be done, for example in that the rotor is further radiated by a radiation source 49 so that the hardening is continued by further cross-linking up the embrittlement. If the stiffening webs 48 are embrittled, they can break on their own or can be broken simply on the removal of the pump by retracting the pump head into the hollow catheter 49.

FIG. 14 shows the reinforcement webs 48 within the conveying blades 37 in the kinked or broken state, as the pump head is pulled back together with the housing 36 into the funnel-shaped distal end of the hollow catheter 49 by means of the drive shaft 46. The retraction can, however, also take place by other means such as pulls extending parallel to the drive shaft 46 in the hollow catheter 49.

In the manner described, the pump head can be pulled into the hollow catheter without any greater mechanical resistance and can be removed together with it out of the ventricle or through the blood vessel out of the patient's body.

Alternatively to the continuation of the hardening process, which was utilized after the transport to stiffen the rotor, up to the embrittlement, a treatment can also take place which is different from the initial stiffening treatment. An embrittlement or a breaking can, for example, be provided by ultrasound treatment. A temperature lowering can also be locally effected, for example, by introduction of a coolant through the hollow catheter 49 in order to embrittle the rotor and/or the pump housing and to make it susceptible to breaking. It is the most sensible in this respect accordingly only to break the rotor and to leave the pump housing intact so that any breaking splinters which may occur cannot enter into the bloodstream.

In FIGS. 15 and 16, a possible erection mechanism is shown for a rotor after the transport and for the transition to the operating state.

In FIG. 15, a rotor is shown having the hub 50 and the conveying blades 51 in the compressed state within the hollow catheter 52 shortly before it is pushed out of the hollow catheter within the ventricle in the direction of the arrow 53. The pushing out can take place by means of the drive shaft 54 or by means of further wires or pulls, not shown. In this state, the rotor is still unhardened and movable. Once it has been moved out of the hollow catheter, it is also alternatively or additionally possible, in addition to other possibilities of expansion, to retract the rotor subsequently a little in the direction of the arrow 55 in FIG. 16 so that the conveying blades 51 abut the edge of the distal end of the hollow catheter 52 by the abutment and are erected radially in the direction of the arrows 56, 57. A hardening of the rotor or only of the conveying blades or of parts of the conveying blades can then take place so that the rotor is stabilized in expanded form. The rotor can thereupon again be pushed out of the hollow catheter 52 in the direction of the arrow 53 and can be pushed away therefrom to reach the operating position. In the above observation, the housing of the pump has been left out of consideration; however, it will be additionally provided in the predominant number of embodiments and will surround the rotor.

FIG. 17 shows a further embodiment of a rotor having a hub 58 to which the conveying blades 59 are fastened. After the moving out of the hollow catheter 60, in a similar manner as shown in FIG. 15, the rotor or the conveying blades of the rotor can be erected by a pushing up of an erection wheel 61 which is shown more clearly in the plan view in FIG. 18. The erection wheel 61 is effected by pushing by means of a plurality of thrust elements 63, 64 or by means of a hose-like element which extends within the hollow catheter 60 and which can, for example, surround the drive shaft 65.

In the erected state of the rotor, it is then hardened and then the erection wheel 61 can be retracted into the hollow catheter 60. The erection wheel 61 is provided with large passage openings 66 in order not to impair or only minimally to impair the flow relationships of the pump.

As a supplement to all the above-named examples and also usable as an independent invention, it is moreover also possible to cause the process of the hardening and/or of the softening of the apparatus in each case by a brief effect of a pulse, of an electromagnetic field or of a similar influence so that the respective duration of influence is limited to the minimally required degree. The crystallization process of the liquid can thus, for example, be triggered by a brief mechanical pulse, similar to the procedure with so-called heat packs. The corresponding crystallized medium can then be liquefied again by a brief local heat effect. By adding to the medium metal particles, for example, which have been excited in a corresponding field, the heat effect could be locally limited so much that any damage to the surrounding tissue is reduced to a non-harmful degree or is completely avoided.

The apparatus in accordance with the invention and the methods in accordance with the invention allow the influencing of the mechanical properties of elements of an apparatus, especially a blood pump, introduced into a patient's body using a technically clear-cut effort so that said apparatus can be brought into the suitable form for operation or can be provided with the required stiffness without the corresponding mechanical properties already having to be present on the introduction into the patient's body. New design forms of corresponding apparatus/pumps thereby become possible.

Er, Sami, Liebing, Reiner, Schlicht, Henning, Wiessler, Petra, Friedel, Sven-Rene

Patent Priority Assignee Title
11648387, May 18 2015 MAGENTA MEDICAL LTD. Blood pump
11648391, Mar 13 2013 MAGENTA MEDICAL LTD. Blood pump
11648392, Nov 23 2016 MAGENTA MEDICAL LTD. Blood pumps
11666747, Jan 24 2019 MAGENTA MEDICAL LTD. Manufacturing an impeller
11684275, Jan 10 2018 MAGENTA MEDICAL LTD. Distal tip element for blood pump
11690521, Jan 10 2018 MAGENTA MEDICAL LTD. Impeller for blood pump
11806116, Jan 10 2018 MAGENTA MEDICAL LTD. Sensor for blood pump
11806117, Jan 10 2018 MAGENTA MEDICAL LTD. Drive cable for blood pump
11839540, Jun 06 2012 MAGENTA MEDICAL LTD Vena-caval apparatus and methods
11839754, Oct 25 2016 MAGENTA MEDICAL LTD Ventricular assist device
11844592, Jan 10 2018 MAGENTA MEDICAL LTD. Impeller and frame for blood pump
11850415, Mar 13 2013 MAGENTA MEDICAL LTD. Blood pump
11883274, Mar 13 2013 MAGENTA MEDICAL LTD. Vena-caval blood pump
Patent Priority Assignee Title
3510229,
3568659,
3802551,
3812812,
4014317, Feb 18 1972 The United States of America as represented by the Department of Health, Multipurpose cardiocirculatory assist cannula and methods of use thereof
4207028, Jun 12 1979 Extendable and retractable propeller for watercraft
4559951, Nov 29 1982 Cardiac Pacemakers, Inc. Catheter assembly
4563181, Feb 18 1983 Merit Medical Systems, Inc Fused flexible tip catheter
4679558, Aug 12 1985 Kensey Nash Corporation Catheter based surgical methods and apparatus therefor
4686982, Jun 19 1985 Kensey Nash Corporation Spiral wire bearing for rotating wire drive catheter
4747821, Oct 22 1986 Kensey Nash Corporation Catheter with high speed moving working head
4749376, Oct 24 1986 Kensey Nash Corporation Reciprocating working head catheter
4753221, Oct 22 1986 Kensey Nash Corporation Blood pumping catheter and method of use
4801243, Dec 28 1985 ROLLS-ROYCE NAVAL MARINE, INC Adjustable diameter screw propeller
4817613, Jul 13 1987 Advanced Cardiovascular Systems, INC Guiding catheter
4919647, Oct 13 1988 Kensey Nash Corporation Aortically located blood pumping catheter and method of use
4957504, Dec 02 1988 Implantable blood pump
4969865, Jan 09 1989 University of Houston System Helifoil pump
4995857, Apr 07 1989 Left ventricular assist device and method for temporary and permanent procedures
5011469, Aug 29 1988 SORIN BIOMEDICAL INC Peripheral cardiopulmonary bypass and coronary reperfusion system
5040944, Sep 11 1989 COOK, JERRY E , EXECTUOR; K J J COOK LAND COMPANY Pump having impeller rotational about convoluted stationary member
5042984, Aug 17 1989 KENSEY NASH CORPORATION, A CORP OF DE Catheter with working head having selectable impacting surfaces and method of using the same
5052404, Mar 02 1989 MICROSPRING COMPANY, LLC, THE Torque transmitter
5061256, Dec 07 1987 Medtronic, Inc Inflow cannula for intravascular blood pumps
5092844, Apr 10 1990 Mayo Foundation for Medical Education and Research Intracatheter perfusion pump apparatus and method
5097849, Aug 17 1989 Kensey Nash Corporation Method of use of catheter with working head having selectable impacting surfaces
5108411, Mar 28 1990 Boston Scientific Scimed, Inc Flexible catheter drive cable
5112292, Jan 09 1989 American BioMed, Inc. Helifoil pump
5113872, Apr 18 1990 Cordis Corporation Guidewire extension system with connectors
5117838, Apr 18 1990 Cordis Corporation Rotating guidewire extension system
5118264, Jan 11 1990 The Cleveland Clinic Foundation Purge flow control in rotary blood pumps
5145333, Mar 01 1990 The Cleveland Clinic Foundation Fluid motor driven blood pump
5163910, Apr 10 1990 Mayo Foundation for Medical Education and Research Intracatheter perfusion pump apparatus and method
5169378, Jul 26 1990 CARDIALCARE, INC ; BIOMED S A Intra-ventricular expansible assist pump
5183384, May 16 1988 Foldable propeller assembly
5191888, Apr 18 1990 Cordis Corporation Assembly of an extension guidewire and an alignment tool for same
5201679, Dec 13 1991 MICHIGAN WHEEL OPERATIONS, LLC Marine propeller with breakaway hub
5275580, Mar 08 1990 Kenji, Yamazaki; Sun Medical Technology Research Corporation Auxiliary artificial heart of the embedded-in-body type
5373619, Sep 30 1987 LAKE REGION MANUFACTURING, INC Method of making a hollow lumen cable
5376114, Oct 30 1992 Cannula pumps for temporary cardiac support and methods of their application and use
5501574, Jun 28 1993 Jostra Bentley Inc Blood pump
5531789, Dec 24 1993 Sun Medical Technology Research Corporation Sealing system of an artificial internal organ
5701911, Apr 05 1996 Medtronic, Inc. Guide wire extension docking system
5755784, Oct 30 1992 Cannula pumps for temporary cardiac support and methods of their application and use
5776190, Oct 30 1992 Cannula pumps for temporary cardiac support and methods of their application and use
5813405, Jul 23 1991 Cordis Corporation Snap-in connection assembly for extension guidewire system
5820571, Jun 24 1996 Medtronic Ave, Inc Medical backloading wire
5851174, Sep 17 1996 United States Surgical Corporation Cardiac support device
5882329, Feb 12 1997 PROLIFIX MEDICAL, INC Apparatus and method for removing stenotic material from stents
5888241, Oct 30 1992 Cannula pumps for temporary cardiac support and methods of their application and use
5938672, Jul 26 1996 Kensey Nash Corporation System and method of use for revascularizing stenotic bypass grafts and other blood vessels
6030397, Dec 21 1998 Covidien LP Miniaturized medical brush
6129704, Jun 12 1997 SciMed Life Systems, INC; Boston Scientific Scimed, Inc Perfusion balloon catheter having a magnetically driven impeller
6152693, Dec 23 1993 Gori marine as Folding propeller
6168624, May 21 1996 Apparatus and methods for revascularization and perfusion
6254359, May 10 1996 The United States of America as represented by the Administrator of the Method for providing a jewel bearing for supporting a pump rotor shaft
6302910, Jun 23 1992 Sun Medical Technology Research Corporation Auxiliary artificial heart of an embedded type
6308632, Nov 23 1998 INTERNATIONAL DYNAMICS CORPORATION, A FLORIDA CORPORATION Deployable folded propeller assembly for aerial projectiles
6336939, Jun 23 1992 Sun Medical Technology Research Corporation Auxiliary artificial heart of an embedded type
6346120, Jun 23 1992 Sun Medical Technology Research Corporation Auxiliary artificial heart of an embedded type
6387125, Jun 23 1992 Sun Medical Technology Research Corporation Auxiliary artificial heart of an embedded type
6491672, Feb 10 2000 LUK, AUTOMOBILTECHNIK GMBH & CO KG Transurethral volume reduction of the prostate (TUVOR)
6503224, Jun 12 1997 SciMed Life Systems, INC; Boston Scientific Scimed, Inc Perfusion balloon catheter
6506025, Jun 23 1999 California Institute of Technology Bladeless pump
6508787, Sep 26 1995 Fraunhofer-Gesellschaft zur Foerderung der Angewandten Forschung E.V. System for actively supporting the flow of body fluids
6517315, May 29 2001 HEWLETT-PACKARD DEVELOPMENT COMPANY, L P Enhanced performance fan with the use of winglets
6527521, Jan 26 2000 Nipro Corporation Magnetically driven axial-flow pump
6533716, Mar 07 1998 AIS GMBH, ALSO KNOWN AS AACHEN INNOVATIVE SOLUTIONS Self-deploying axial-flow pump introduced intravascularly for temporary cardiac support
6537030, Oct 18 2000 Regal Beloit America, Inc Single piece impeller having radial output
6537315, Jun 23 1992 Sun Medical Technology Research Corporation Auxiliary artificial heart of an embedded type
6592612, May 04 2000 Cardeon Corporation Method and apparatus for providing heat exchange within a catheter body
6652548, Mar 31 2000 Covidien LP Expansible shearing catheters for thrombus removal
6719791, Apr 20 1999 Berlin Heart GmbH Device for the axial transport of fluid media
6860713, Nov 27 2002 NIDEC CORPORATION Fan with collapsible blades, redundant fan system, and related method
6945977, Dec 06 1999 Covidien LP Systems and methods for clot disruption and retrieval
6981942, Nov 19 2001 Rutgers, The State University of New Jersey Temporary blood circulation assist device
7022100, Sep 03 1999 MAQUET CARDIOVASCULAR, LLC, A DELAWARE CORPORATION Guidable intravascular blood pump and related methods
7027875, Dec 01 2000 Impella Cardiosystems GmbH Intravascular pump
7074018, Jul 10 2003 Direct drive linear flow blood pump
7179273, Jun 21 1999 Endovascular Technologies, Inc. Filter/emboli extractor for use in variable sized blood vessels
7393181, Sep 17 2004 THORATEC LLC; TC1 LLC Expandable impeller pump
7467929, Feb 16 2001 Berlin Heart GmbH Device for axially conveying fluids
7648619, Jun 04 2002 Industrial Technology Research Hydrogel-driven micropump
7731675, Sep 03 1999 MAQUET CARDIOVASCULAR, LLC, A DELAWARE CORPORATION Guidable intravascular blood pump and related methods
7878967, Oct 06 2005 KHANAL, SANJAYA Heart failure/hemodynamic device
7927068, Sep 17 2004 THORATEC LLC; TC1 LLC Expandable impeller pump
7934909, Feb 16 2001 Berlin Heart GmbH Device for axially conveying fluids
7942804, May 20 2004 COR-MED VASCULAR, INC Replaceable expandable transmyocardial ventricular assist device
8048086, Feb 25 2004 Femasys Inc.; FEMASYS INC Methods and devices for conduit occlusion
8052669, Feb 25 2004 FEMASYS INC Methods and devices for delivery of compositions to conduits
20020123661,
20030135086,
20030231959,
20040044266,
20040093074,
20040215222,
20040215228,
20060008349,
20060062672,
20060195004,
20080132747,
20080262584,
20080306327,
20090060743,
20090093764,
20090093796,
20090234278,
20100036360,
20100041939,
20100268017,
20110236210,
20110238172,
20110275884,
20120016456,
20120039711,
20120041254,
20120046260,
20120046648,
20120093628,
20120101455,
20120142994,
20120184803,
20120224970,
20120234411,
20120237353,
20120237357,
20120264523,
20120265002,
20120294727,
20120301318,
20120308406,
20130019968,
20130041202,
20130060077,
20130066139,
20130085318,
20130177409,
20130177432,
20130204362,
20130237744,
20140039465,
CA1008330,
CA2311977,
CA2701809,
CA2701810,
CN101448542,
CN102834126,
DE10059714,
DE10108810,
DE10155011,
DE102010011998,
DE10336902,
DE19535781,
DE19711935,
DE2113986,
DE2207296,
DE2233293,
DE2613696,
DE29804046,
DE4124299,
DE69017784,
DE69103295,
DE69407869,
DE69427390,
DE69431204,
EP916359,
EP1019117,
EP1066851,
EP1114648,
EP1337288,
EP1651290,
EP2218469,
EP2229965,
EP2301598,
EP2308524,
EP2343091,
EP2345440,
EP2366412,
EP2497521,
EP2606919,
EP2606920,
EP2607712,
EP480102,
EP560000,
EP629412,
EP768091,
EP884064,
EP914171,
EP951302,
GB2239675,
GB536245,
RU2229899,
WO27446,
WO43054,
WO62842,
WO2001007760,
WO2001007787,
WO2001083016,
WO2003057013,
WO2003103745,
WO2005002646,
WO2005016416,
WO2005021078,
WO2005030316,
WO2005032620,
WO2005081681,
WO2006020942,
WO2006034158,
WO2006133209,
WO2007003351,
WO2007103390,
WO2007103464,
WO2007112033,
WO2007135577,
WO2008017289,
WO2008034068,
WO2008054699,
WO2008106103,
WO2008116765,
WO2008124696,
WO2008137352,
WO2008137353,
WO2009015784,
WO2009132309,
WO2010133567,
WO2013034547,
WO2013092971,
WO2013093001,
WO2013093058,
WO9202263,
WO9302732,
WO9303786,
WO9314805,
WO94001148,
WO9405347,
WO9409835,
WO9420165,
WO9523000,
WO9618358,
WO9625969,
WO9744071,
WO9853864,
WO9919017,
//////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 31 2012FRIEDEL, SVEN-RENÉECP ENTWICKLUNGSGESELLSCHAFT MBHASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0458800938 pdf
Nov 01 2012ER, SAMIECP ENTWICKLUNGSGESELLSCHAFT MBHASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0458800938 pdf
Nov 05 2012WIESSLER, PETRAECP ENTWICKLUNGSGESELLSCHAFT MBHASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0458800938 pdf
Nov 05 2012LIEBING, REINERECP ENTWICKLUNGSGESELLSCHAFT MBHASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0458800938 pdf
Nov 05 2012SCHLICHT, HENNINGECP ENTWICKLUNGSGESELLSCHAFT MBHASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0458800938 pdf
Jan 17 2018ECP ENTWICKLUNGSGESELLSCHAFT MBH(assignment on the face of the patent)
Date Maintenance Fee Events
Jan 17 2018BIG: Entity status set to Undiscounted (note the period is included in the code).
Feb 21 2023M1551: Payment of Maintenance Fee, 4th Year, Large Entity.


Date Maintenance Schedule
Sep 17 20224 years fee payment window open
Mar 17 20236 months grace period start (w surcharge)
Sep 17 2023patent expiry (for year 4)
Sep 17 20252 years to revive unintentionally abandoned end. (for year 4)
Sep 17 20268 years fee payment window open
Mar 17 20276 months grace period start (w surcharge)
Sep 17 2027patent expiry (for year 8)
Sep 17 20292 years to revive unintentionally abandoned end. (for year 8)
Sep 17 203012 years fee payment window open
Mar 17 20316 months grace period start (w surcharge)
Sep 17 2031patent expiry (for year 12)
Sep 17 20332 years to revive unintentionally abandoned end. (for year 12)